Adults With Arthritis Suffer With Poorer Health Related Quality Of Life

Main Category: Arthritis / Rheumatology
Article Date: 27 Apr 2011 – 21:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:1 star

1 (2 votes)

Healthcare Prof:not yet rated

A new study reports that the health-related quality of life (HRQOL)
for U.S. adults with arthritis is much worse than for those without
this condition. Both physical and mental health are affected by
arthritis, which poses a significant health and economic burden as the
number of those diagnosed continues to climb. Details of this study
are now online in Arthritis Care Research, a journal published by
Wiley-Blackwell on behalf of the American College of Rheumatology
(ACR).

Tofacitinib Effective In Helping Rheumatoid Arthritis Patients, Trial Results Find

Editor’s Choice
Main Category: Arthritis / Rheumatology
Article Date: 29 Apr 2011 – 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:2 stars

2 (1 votes)

Article Opinions: 1 posts

Adding Tofacitinib to standard treatment has been shown to be more effective than standard rheumatoid arthritis treatment alone, according to top-line results of two Phase 3 Trials, pharmaceutical giant Pfizer announced. The company says results details will be presented at a future scientific meeting.

The two trials were called ORAL Standard and ORAL Step.

Celebrating 12 years of hope & health in Haiti

Twelve years ago, TriMedx volunteers responded to a plea by Sister Martha Barlai-Kovach of CRUDEM, relaying the urgent need for working medical equipment at Hôpital Sacré Coeur in Milot, Haiti. It was then, in 1999, that our mission of hope began. Without working medical equipment, mission hospitals like Hôpital Sacré Coeur lack the tools to perform some of the most basic life-saving procedures.

And so in 2004 the TriMedx Foundation was formed to meet this need around the world. Since then, TriMedx Foundation has been a primary resource to Hôpital Sacré Coeur in providing healthcare equipment, technology training and support.

Buy Recertified Chemistry Analyzers

Buying recertified chemistry analyzers are an economical option for laboratories as they offer accurate results.

Chemistry analyzers are indispensable when it comes to tests for a variety of routine chemistry analytes. Buying recertified chemistry analyzers are an economical option for laboratories as they offer accurate results while costing just a fraction of the price of new equipment.

Recertified Models Chemistry Analyzers – Points to Consider

Chemistry analyzers perform tests for analytes like bilirubin, magnesium, albumin, creatinine, calcium, uric acid, inorganic phosphorus, urea nitrogen (bun), glucose, and iron. They also provide assays for analytics such as thyroid, therapeutic drug, lipid, electrolyte, drugs of abuse, and so on. Labs that plan on buying recertified models should bear the following points in mind:

FDA Approves Updated, Clarified Indication For Use For IFuse Implant System®

Main Category: Arthritis / Rheumatology
Also Included In: Regulatory Affairs / Drug Approvals;  Medical Devices / Diagnostics
Article Date: 28 Apr 2011 – 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (1 votes)

SI-BONE, Inc. (San Jose, California), a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to treat the sacroiliac (SI) joint announced the U.S. Food and Drug Administration (FDA) approved a major modification to the existing product label. The Approval targets the use of iFuse Implant System® for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

Pfizer’s Tofacitinib Takes Next Step To Combat Arthritis

Editor’s Choice
Main Category: Arthritis / Rheumatology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 28 Apr 2011 – 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:4 and a half stars

4.5 (2 votes)

Healthcare Prof:5 stars

5 (1 votes)

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that typically affects the hands and feet, although any joint lined by a synovial membrane may be affected. Now Pfizer has announced progress for their drug tofacitinib. Tofacitinib is a unique, oral Janus kinase (JAK) inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for RA.

Administration Implements Affordable Care Act Provision To Improve Care, Lower Costs

Main Category: Medicare / Medicaid / SCHIP
Article Date: 29 Apr 2011 – 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

The Department of Health and Human Services (HHS) has launched a new initiative which will reward hospitals for the quality of care they provide to people with Medicare and help reduce health care costs. Authorized by the Affordable Care Act, the Hospital Value-Based Purchasing program marks the beginning of an historic change in how Medicare pays health care providers and facilities-for the first time, 3,500 hospitals across the country will be paid for inpatient acute care services based on care quality, not just the quantity of the services they provide.

Canadian Doctors For Medicare: Tory Silence On Medicare Pledge “Deafening”

Main Category: Medicare / Medicaid / SCHIP
Article Date: 29 Apr 2011 – 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

Stephen Harper’s decision to refuse even the most basic commitment to Medicare has caused surprise and concern among Canadians who care about our health care system. Hundreds of local candidates representing the Liberal, New Democratic and Green Parties, and all three of their National Leaders, have given their support to the Health Care Protection Pledge, a commitment to sustain Medicare past the 2014 Health Accord negotiations. Stephen Harper is the only national leader who has chosen not to express support for our health care system, and all but two Conservative candidates have followed his lead, almost universally refusing to make a commitment to Medicare.

Waiting for the storm to hit

I know the whole “calm before the storm” thing is a little cliché.  Sorry.  It just really seems to fit how I feel.  So I’ll just get it over with and say that I’m in the calm before the storm. 

I’m now on my full zofran regime.  I had to start that yesterday at work.  8 mg every 6 hours.  I’m not waking to take it through the night.  Yet. 

I’m becoming a slave to the clock.

5:45 AM: stick zofran in mouth and lay back down.

7:00 AM: multivitamin, ginger, unisom/B6, colace, pepcid, folic acid

The Undrugging of Annie (Part VII)

            I battled the system for proper treatment—said treatment now consisting of things like aide service, a shower chair and a tray table.  The nurse/case manager was from a religious order and I was required to call her “Sister” even though she entered my life as a nurse, not a religious.  She was appallingly ill willed but some of the aides touched my heart.  The occupational therapist was as helpful as a Nazi death camp guard, nevertheless, I got a shower chair and handheld shower.  Medicare paid $2000 for a $500 hospital bed, calling it a “necessity,” but refused to buy a $100 tray table to go with the bed, calling it a “convenience.”  I ate supper off a $2000 laptop computer.